- Home
- IOTR vs SCYX Comparison
IOTR vs SCYX Comparison
Compare IOTR & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- SCYX
- Stock Information
- Founded
- IOTR 2019
- SCYX 1999
- Country
- IOTR Singapore
- SCYX United States
- Employees
- IOTR N/A
- SCYX N/A
- Industry
- IOTR
- SCYX Biotechnology: Pharmaceutical Preparations
- Sector
- IOTR
- SCYX Health Care
- Exchange
- IOTR NYSE
- SCYX Nasdaq
- Market Cap
- IOTR 29.5M
- SCYX 28.5M
- IPO Year
- IOTR 2025
- SCYX 2014
- Fundamental
- Price
- IOTR $0.49
- SCYX $0.72
- Analyst Decision
- IOTR
- SCYX
- Analyst Count
- IOTR 0
- SCYX 0
- Target Price
- IOTR N/A
- SCYX N/A
- AVG Volume (30 Days)
- IOTR 548.2K
- SCYX 200.7K
- Earning Date
- IOTR 01-01-0001
- SCYX 08-07-2025
- Dividend Yield
- IOTR N/A
- SCYX N/A
- EPS Growth
- IOTR N/A
- SCYX N/A
- EPS
- IOTR N/A
- SCYX N/A
- Revenue
- IOTR $10,478,550.00
- SCYX $2,630,000.00
- Revenue This Year
- IOTR N/A
- SCYX $410.22
- Revenue Next Year
- IOTR N/A
- SCYX $248.83
- P/E Ratio
- IOTR N/A
- SCYX N/A
- Revenue Growth
- IOTR 22.27
- SCYX N/A
- 52 Week Low
- IOTR $0.31
- SCYX $0.66
- 52 Week High
- IOTR $5.98
- SCYX $2.28
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- SCYX 46.77
- Support Level
- IOTR N/A
- SCYX $0.67
- Resistance Level
- IOTR N/A
- SCYX $0.83
- Average True Range (ATR)
- IOTR 0.00
- SCYX 0.05
- MACD
- IOTR 0.00
- SCYX 0.01
- Stochastic Oscillator
- IOTR 0.00
- SCYX 46.35
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.